SPARC EXPRESSION IS ASSOCIATED WITH METASTATIC PROGRESSION AND PROSTATE CANCER-SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY

被引:0
|
作者
Jeldres, Claudio
Johnston, Richard
Porter, Christopher
机构
来源
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词
D O I
10.1016/j.juro.2013.02.350
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
786
引用
收藏
页码:E324 / E324
页数:1
相关论文
共 50 条
  • [1] Association of SPARC expression with metastatic progression and prostate cancer-specific mortality after radical prostatectomy
    Jeldres, Claudio
    Johnston, Richard Bruce
    Porter, Christopher R.
    Nelson, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A Nomogram Predicting Prostate Cancer-Specific Mortality after Radical Prostatectomy
    Porter, Christopher R.
    Suardi, Nazareno
    Capitanio, Umberto
    Hutterer, Georg C.
    Kodama, Koichi
    Gibbons, Robert P.
    Correa, Roy, Jr.
    Perrotte, Paul
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    [J]. UROLOGIA INTERNATIONALIS, 2010, 84 (02) : 132 - 140
  • [3] Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy
    Zhou, P
    Chen, MH
    McLeod, D
    Carroll, PR
    Moul, JW
    D'Amico, AV
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6992 - 6998
  • [4] Prostate cancer-specific mortality after radical prostatectomy: value of preoperative MRI
    Woo, Sungmin
    Cho, Jeong Yeon
    Ku, Ja Hyeon
    Kim, Sang Youn
    Kim, Seung Hyup
    [J]. ACTA RADIOLOGICA, 2016, 57 (08) : 1006 - 1013
  • [5] Impact of marital status on prostate cancer-specific mortality and overall mortality after radical prostatectomy
    Nepple, Kenneth Gerard
    Kibel, Adam Stuart
    Sandhu, Gurdarshan S.
    Kallogjeri, Dorina
    Strope, Seth A.
    Grubb, Robert L.
    Wolin, Kathleen Y.
    Sutcliffe, Siobhan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [6] Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
    Freedland, SJ
    Humphreys, EB
    Mangold, LA
    Eisenberger, M
    Dorey, FJ
    Walsh, PC
    Partin, AW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04): : 433 - 439
  • [7] Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy
    Yossepowitch, Ofer
    Eggener, Scott E.
    Serio, Angel M.
    Caruer, Brett S.
    Bianco, Fernando J., Jr.
    Scardino, Peter T.
    Eastham, James A.
    [J]. EUROPEAN UROLOGY, 2008, 53 (05) : 950 - 959
  • [8] Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
    Stephenson, Andrew J.
    Kattan, Michael W.
    Eastham, James A.
    Bianco, Fernando J., Jr.
    Yossepowitch, Ofer
    Vickers, Andrew J.
    Klein, Eric A.
    Wood, David P.
    Scardino, Peter T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4300 - 4305
  • [9] Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era
    Stephenson, Andrew J.
    Kattan, Michael W.
    Eastham, James A.
    Klein, Eric A.
    Bianco, Fernando J.
    Vickers, Andrew J.
    Yossepowitch, Ofer
    Scardino, Peter T.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 649 - 649
  • [10] Impact of preoperative risk on metastatic progression and cancer-specific mortality in patients with adverse pathology at radical prostatectomy
    Boehm, Katharina
    Leyh-Bannurah, Sami-Ramzi
    Rosenbaum, Clemens
    Brandi, Laurenz S.
    Budaeus, Lars
    Graefen, Markus
    Huland, Hartwig
    Haferkamp, Axel
    Tilki, Derya
    [J]. BJU INTERNATIONAL, 2017, 120 (05) : 666 - 672